Literature DB >> 12454689

Epidemiology of Peyronie's disease.

F Sommer1, U Schwarzer, G Wassmer, W Bloch, M Braun, T Klotz, U Engelmann.   

Abstract

Francois Gigot de la Peyronie, surgeon to Louis XV of France, has become synonymous with the rather enigmatic though not uncommon condition of Peyronie's disease (PD), a localized connective tissue disorder of the penile tunica albuginea. The true prevalence of Peyronie's disease is unknown. Therefore, we decided to perform an evaluation of existing epidemiological data. A prevalence rate of 3.2% was determined in male inhabitants of the greater Cologne area. This is much higher than revealed by the data reported up to now, thus rendering the accepted prevalence rates of 0.3% to 1% untenable. The actual prevalence of Peyronie's disease may be even higher, considering many patients' reluctance to report this embarrassing condition to their physicians. Along these lines, most clinicians note that the number of Peyronie's patients has increased since the advent of oral sildenafil. Comparably high prevalences are known for diabetes and urolithiasis, suggesting a greater frequency of this rare disease than formerly believed.

Entities:  

Mesh:

Year:  2002        PMID: 12454689     DOI: 10.1038/sj.ijir.3900863

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  28 in total

1.  [Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Authors:  E W Hauck; T Bschleipfer; S M Haag; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

2.  Update on plication procedures for Peyronie's disease and other penile deformities.

Authors:  Elizabeth M Mobley; Molly E Fuchs; Jeremy B Myers; William O Brant
Journal:  Ther Adv Urol       Date:  2012-12

3.  Penile plication for Peyronie's disease: our results with mean follow-up of 103 months on 89 patients.

Authors:  U Cantoro; M Polito; F Catanzariti; L Montesi; V Lacetera; G Muzzonigro
Journal:  Int J Impot Res       Date:  2014-02-27       Impact factor: 2.896

Review 4.  2013-2014 updates in Peyronie's disease management.

Authors:  Benjamin A Sherer; Krishnan Warrior; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

Review 5.  Peyronie's Disease: Intralesional Therapy and Surgical Intervention.

Authors:  Louis A Aliperti; Akanksha Mehta
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

Review 6.  Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.

Authors:  Elizabeth J Traore; William Wang; Faysal A Yafi; Wayne J G Hellstrom
Journal:  Ther Adv Urol       Date:  2016-03-22

Review 7.  Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections.

Authors:  Mahdi Bazzi; Marcus L Jamil; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2019-06-14       Impact factor: 3.092

Review 8.  The Genetic Basis of Peyronie Disease: A Review.

Authors:  Amin S Herati; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-01-08

9.  A novel modification of tunical plication by plaque thinning: long-term results in treating penile curvature of Peyronie's disease.

Authors:  Sentai Ding; Jiajü Lü; Hui Zhang; Lijing Wei; Kejia Ding
Journal:  Int Urol Nephrol       Date:  2009-11-24       Impact factor: 2.370

10.  Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease.

Authors:  Carolin Szardening-Kirchner; Lutz Konrad; Ekkehard W Hauck; Simone M Haag; Oliver Eickelberg; Wolfgang Weidner
Journal:  World J Urol       Date:  2008-08-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.